Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators..

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.

PMID:
22572202
2.

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW; TRACER Investigators..

N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13.

3.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators..

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

4.

Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism.

Lewis DA, Stashenko GJ, Akay OM, Price LI, Owzar K, Ginsburg GS, Chi JT, Ortel TL.

Thromb Res. 2011 Dec;128(6):536-40. doi: 10.1016/j.thromres.2011.06.003. Epub 2011 Jul 7.

5.

Effect of home testing of international normalized ratio on clinical events.

Matchar DB, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs CS, Vertrees JE, Shih MC, Holodniy M, Lavori P; THINRS Executive Committee and Site Investigators..

N Engl J Med. 2010 Oct 21;363(17):1608-20. doi: 10.1056/NEJMoa1002617. Erratum in: N Engl J Med. 2011 Jan 6;364(1):93.

6.

Prophylaxis for venous thromboembolism: guidelines translated for the clinician.

Stashenko G, Lopes RD, Garcia D, Alexander JH, Tapson VF.

J Thromb Thrombolysis. 2011 Jan;31(1):122-32. doi: 10.1007/s11239-010-0522-0. Review.

PMID:
20936495
7.

An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS).

Dolor RJ, Ruybalid RL, Uyeda L, Edson RG, Phibbs C, Vertrees JE, Shih MC, Jacobson AK, Matchar DB; THINRS Site Investigators..

J Thromb Thrombolysis. 2010 Oct;30(3):263-75. doi: 10.1007/s11239-010-0499-8.

PMID:
20628787
8.

Treatment of venous thromboembolism: guidelines translated for the clinician.

Houman Fekrazad M, Lopes RD, Stashenko GJ, Alexander JH, Garcia D.

J Thromb Thrombolysis. 2009 Oct;28(3):270-5. doi: 10.1007/s11239-009-0374-7.

PMID:
19579012
9.

Prevention of venous thromboembolism in medical patients and outpatients.

Stashenko GJ, Tapson VF.

Nat Rev Cardiol. 2009 May;6(5):356-63. doi: 10.1038/nrcardio.2009.33. Review.

PMID:
19377498
10.

Thrombolytic therapy for venous thromboembolism: current clinical practice.

Stashenko GJ, Hargett CW, Tapson VF.

J Hosp Med. 2009 May;4(5):313-6. doi: 10.1002/jhm.421.

PMID:
19266475
11.

Pleural fluid exchange in rabbits.

Stashenko GJ, Robichaux A, Lee YC, Sanders JR, Roselli RJ, Light RW.

Respirology. 2007 Jul;12(4):495-9.

PMID:
17587414

Supplemental Content

Loading ...
Support Center